<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02005939</url>
  </required_header>
  <id_info>
    <org_study_id>POM-01Expl</org_study_id>
    <secondary_id>POM-01Expl</secondary_id>
    <nct_id>NCT02005939</nct_id>
  </id_info>
  <brief_title>Effect of Biophenol-rich Pomegranate Extract Intake on Blood Pressure, Hormones, Body Composition and Quality of Life in Healthy Volunteers.</brief_title>
  <acronym>POM-01Expl</acronym>
  <official_title>Effect of Pomegranate Extract Intake on Anthropometric, Metabolic and Hormonal Parameters in Human Volunteers: a Double Blinded, Placebo Controlled, Randomised, Exploratory 4 Week Trial.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Queen Margaret University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>PomeGreat</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Queen Margaret University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Biophenols can act as powerful antioxidants. Pomegranate (Punica granatum) provides a rich&#xD;
      and varied source of biophenols with the most abundant being ellagitannins, tannins,&#xD;
      anthocyanins, ellagic and gallic acids. Interest in antioxidant polyphenol-rich pomegranate&#xD;
      products has increased in recent years with growing reports of potential health benefits.&#xD;
      Pomegranate biophenols have been noted to lower systolic blood pressure, salivary stress&#xD;
      hormones and increase insulin sensitivity in previous trials involving participants who have&#xD;
      cardiovascular disease, but few studies have been conducted recruiting healthy volunteers,&#xD;
      and those have made use of pomegranate juice rather than extract.&#xD;
&#xD;
      The aim of this parallel study is to investigate the effect of pomegranate extract&#xD;
      supplementation on blood pressure, lipid profiles, salivary stress hormones, insulin&#xD;
      sensitivity, body composition and the perceived quality of life in healthy volunteers over 4&#xD;
      weeks.&#xD;
&#xD;
      It hypothesizes that consumption of biophenol-rich Pomegranate extract could increase insulin&#xD;
      sensitivity and perceived quality of life while decreasing blood pressure, body measurements&#xD;
      and stress hormones in healthy individuals.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      After randomisation to a study arm, eligible participants will consume either one pomegranate&#xD;
      extract or placebo capsule (identical in appearance) daily, for a period of 4 weeks. The&#xD;
      pomegranate capsule contains 650mg of pomegranate extract (240 mg punicalagins and 350mg&#xD;
      total biophenols) and the placebo, maltodextrin.&#xD;
&#xD;
      Participants will be required to attend the university clinic lab twice, having fasted&#xD;
      overnight, with all measurements being taken pre and post study at 4 weeks. Blood, saliva and&#xD;
      24 hr urine samples will be provided. Body weight and composition, dietary habits and quality&#xD;
      of life will also be measured. The well validated health related Quality of Life&#xD;
      Questionnaire (Rand 36) will be administered pre- and post-intervention. This series of&#xD;
      questions covers eight spheres of health. The physical health component considers physical&#xD;
      functioning, physical role, bodily pain and general health. The mental health aspect examines&#xD;
      vitality, social functioning, emotional role and general mental health. Anthropometric&#xD;
      measurements recorded will be height, weight, waist, mid upper arm circumference.&#xD;
      Bioelectrical impedance analysis (BIA), which measures conductivity from hand to foot,&#xD;
      calculating both body fat and fat free mass, will also be performed.&#xD;
&#xD;
      Pre and post study comparison of the amount of polyphenols in 24 hr urine samples provided,&#xD;
      alongside capsule consumption checks, will measure compliance. A 3 day diet diary record,&#xD;
      will be used for recording energy intake and to highlight any fluctuations in dietary intake&#xD;
      over the study period.&#xD;
&#xD;
      The data will be analysed using Statistical Programme for Social Sciences (SPSS) for Windows&#xD;
      software version 19. Differences in baseline characteristics will be examined using&#xD;
      independent t- tests with extract and placebo groups as independent variables and outcome&#xD;
      measures as dependent variables. Paired t-tests will determine any individual differences&#xD;
      between pre and post biochemical markers and anthropometric measurements. ANCOVAs will&#xD;
      determine the overall differences between the independent groups.&#xD;
&#xD;
      This exploratory study will provide a foundation for and refine the outcome measures required&#xD;
      for a larger future trial.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>April 2012</start_date>
  <completion_date type="Actual">July 2012</completion_date>
  <primary_completion_date type="Actual">July 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Blood pressure</measure>
    <time_frame>Week 0, 4</time_frame>
    <description>Change in systolic and diastolic blood pressure</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Changes in insulin sensitivity</measure>
    <time_frame>Week 0, 4</time_frame>
    <description>Measured through fasting insulin and glucose</description>
  </secondary_outcome>
  <other_outcome>
    <measure>stress hormone levels</measure>
    <time_frame>Week 0, 4</time_frame>
    <description>Measured via saliva using ELISA methods</description>
  </other_outcome>
  <other_outcome>
    <measure>Changes in body composition</measure>
    <time_frame>week 0, 4</time_frame>
    <description>Assessed via BMI, body fat mass</description>
  </other_outcome>
  <other_outcome>
    <measure>Quality of Life</measure>
    <time_frame>Week 0, 4</time_frame>
    <description>Assessed by the scored Rand 36 Questionnaire</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">29</enrollment>
  <condition>Cardiovascular Risk Factors</condition>
  <arm_group>
    <arm_group_label>Pomegranate extract capsule</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>All participants receive 1.1 g pomegranate extract capsule daily for 4 weeks</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo capsule</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>All participants receive a 1.1g placebo capsule daily for 4 weeks</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Pomegranate extract</intervention_name>
    <description>All randomised participants to the intervention arm receive one pomegranate capsule daily for 4 weeks</description>
    <arm_group_label>Pomegranate extract capsule</arm_group_label>
    <other_name>Pomegreat PurePlus</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Healthy participants&#xD;
&#xD;
          -  BMI from 18-35&#xD;
&#xD;
          -  Males and Females&#xD;
&#xD;
          -  Age: 18-65 years&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        Systemic disease, including heart disease and diabetes&#xD;
&#xD;
          -  Allergic reactions&#xD;
&#xD;
          -  Alcohol/drug abuse&#xD;
&#xD;
          -  Immunological conditions&#xD;
&#xD;
          -  Pregnancy or lactation&#xD;
&#xD;
          -  Liver and kidney disease&#xD;
&#xD;
          -  Management for weight control within the last 2 months&#xD;
&#xD;
          -  Heavy smokers&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Emad AS Al-Dujaili, Ph.D.</last_name>
    <role>Study Director</role>
    <affiliation>Queen Margaret University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Queen Margaret University</name>
      <address>
        <city>Edinburgh</city>
        <state>Scotland</state>
        <zip>EH21 6UU</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>December 2013</verification_date>
  <study_first_submitted>December 4, 2013</study_first_submitted>
  <study_first_submitted_qc>December 4, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 9, 2013</study_first_posted>
  <last_update_submitted>December 4, 2013</last_update_submitted>
  <last_update_submitted_qc>December 4, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 9, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Queen Margaret University</investigator_affiliation>
    <investigator_full_name>Angela Stockton</investigator_full_name>
    <investigator_title>P.h.D. Researcher</investigator_title>
  </responsible_party>
  <keyword>Pomegranate</keyword>
  <keyword>Blood pressure</keyword>
  <keyword>Insulin sensitivity</keyword>
  <keyword>Cortisol</keyword>
  <keyword>Quality of life</keyword>
  <keyword>Body composition</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

